ProfileGDS4132 / 220381_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 35% 38% 44% 38% 36% 47% 36% 40% 45% 36% 34% 36% 32% 49% 47% 39% 28% 32% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10184.946634
GSM201543Muscle PCOS pioglitazone 12181.348735
GSM201544Muscle PCOS pioglitazone 16198.479338
GSM201545Muscle PCOS pioglitazone 201124.95944
GSM201829Muscle PCOS pioglitazone 231103.07538
GSM201830Muscle PCOS pioglitazon 25193.438936
GSM201831Muscle PCOS pioglitazone 271125.57747
GSM201832Muscle PCOS pioglitazone 3192.418636
GSM201833Muscle PCOS pioglitazone 4196.069840
GSM201834Muscle PCOS pioglitazone 81114.8945
GSM201835Muscle PCOS after pioglitazone 10277.927236
GSM201836Muscle PCOS after pioglitazone 12274.573634
GSM201837Muscle PCOS after pioglitazone 16276.779936
GSM201838Muscle PCOS after pioglitazone 20271.455532
GSM201839Muscle PCOS after pioglitazone 232124.31649
GSM201840Muscle PCOS after pioglitazone 252121.06947
GSM201841Muscle PCOS after pioglitazone 27285.898539
GSM201842Muscle PCOS after pioglitazone 3252.336428
GSM201843Muscle PCOS after pioglitazone 4278.426632
GSM201844Muscle PCOS after pioglitazone 8275.089932